| Refua Pharmacy And Medical Supply | |
| 6404 Reisterstown Road, Baltimore, Maryland 21215 | |
| (410) 585-0055 |
| Name | Refua Pharmacy And Medical Supply |
|---|---|
| Organization Name | Refua Pharmacy And Medical Supply Inc |
| Location | 6404 Reisterstown Road, Baltimore, Maryland 21215 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 585-0055 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Tumor treatment with multispecific antibodies is significantly more tolerable if administered subcutaneously rather than via the bloodstream, which was the standard procedure until now. This was the result of an animal model study undertaken by researchers at Helmholtz Zentrum München in cooperation with the Munich biotech company Trion Research.
Americans who fall short in meeting their daily fruit and vegetable intakes based on government guidelines are also likely to fall short in common bone-building nutrients like calcium and vitamin D, according to a newly released report by the Nutrilite Health Institute called America's Phytonutrient Report: Bone Health by Color.
The innate immune system serves as the body's specialized armed forces division, comprised of a host of defense mechanisms used to battle bacterial infections. Among the system's warriors are white blood cells including the specialized macrophages, which maintain constant surveillance for foreign intruders or pathogens, functioning as the body's first line of defense, poised to attack at barrier sites including the skin, lungs and intestines.
MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now commenced the conformity assessment procedure for its Nano-Cancer ® therapy.
A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease (CVD). In a four-country survey sample of 4,000 adults, 49 per cent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.
› Verified 6 days ago
| NPI Number | 1124394432 |
| Organization Name | REFUA PHARMACY AND MEDICAL SUPPLY INC |
| Doing Business As | REFUA PHARMACY AND MEDICAL SUPPLY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6404 Reisterstown Rd, Baltimore, MD 21215 |
| Phone Number | 410-585-0055 |
News Archive
Tumor treatment with multispecific antibodies is significantly more tolerable if administered subcutaneously rather than via the bloodstream, which was the standard procedure until now. This was the result of an animal model study undertaken by researchers at Helmholtz Zentrum München in cooperation with the Munich biotech company Trion Research.
Americans who fall short in meeting their daily fruit and vegetable intakes based on government guidelines are also likely to fall short in common bone-building nutrients like calcium and vitamin D, according to a newly released report by the Nutrilite Health Institute called America's Phytonutrient Report: Bone Health by Color.
The innate immune system serves as the body's specialized armed forces division, comprised of a host of defense mechanisms used to battle bacterial infections. Among the system's warriors are white blood cells including the specialized macrophages, which maintain constant surveillance for foreign intruders or pathogens, functioning as the body's first line of defense, poised to attack at barrier sites including the skin, lungs and intestines.
MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now commenced the conformity assessment procedure for its Nano-Cancer ® therapy.
A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease (CVD). In a four-country survey sample of 4,000 adults, 49 per cent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.
› Verified 6 days ago
News Archive
Tumor treatment with multispecific antibodies is significantly more tolerable if administered subcutaneously rather than via the bloodstream, which was the standard procedure until now. This was the result of an animal model study undertaken by researchers at Helmholtz Zentrum München in cooperation with the Munich biotech company Trion Research.
Americans who fall short in meeting their daily fruit and vegetable intakes based on government guidelines are also likely to fall short in common bone-building nutrients like calcium and vitamin D, according to a newly released report by the Nutrilite Health Institute called America's Phytonutrient Report: Bone Health by Color.
The innate immune system serves as the body's specialized armed forces division, comprised of a host of defense mechanisms used to battle bacterial infections. Among the system's warriors are white blood cells including the specialized macrophages, which maintain constant surveillance for foreign intruders or pathogens, functioning as the body's first line of defense, poised to attack at barrier sites including the skin, lungs and intestines.
MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now commenced the conformity assessment procedure for its Nano-Cancer ® therapy.
A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease (CVD). In a four-country survey sample of 4,000 adults, 49 per cent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.
› Verified 6 days ago
Santa Monica Pharmacy And Medical S Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4300 Belair Rd, Baltimore, Maryland 21206 Phone: (410) 617-0116 | |
Rite Aid Pharmacy 00349 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4380 Park Heights Ave, Baltimore, Maryland 21215 Phone: (410) 664-8644 | |
Rite Aid Pharmacy 02214 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2855 Smith Ave, Baltimore, Maryland 21209 Phone: (410) 484-3200 | |
Rite Aid Pharmacy 00356 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3804 Liberty Heights Ave, Baltimore, Maryland 21215 Phone: (410) 367-5151 | |
Rite Aid Pharmacy 00385 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5804 Ritchie Hwy, Baltimore, Maryland 21225 Phone: (410) 789-3775 |